Notification filed by National Security Exchange to report the removal from listing and registration of matured, redeemed or retired securities Initial Filing Amendments
Download
Date
October 13, 2026
Type
8-K
Description
Current report filing
Download
Date
October 01, 2026
Type
4
Description
Statement of Changes in Beneficial Ownership
Download
Date
October 01, 2026
Type
4
Description
Statement of Changes in Beneficial Ownership
Download
Date
October 01, 2026
Type
4
Description
Statement of Changes in Beneficial Ownership
Download
Date
September 01, 2026
Type
3
Description
Initial Statement of Beneficial Ownership
Download
Date
August 13, 2026
Type
4
Description
Statement of Changes in Beneficial Ownership
Download
Date
August 13, 2026
Type
144
Description
Report of proposed sale of securities
Download
Date
August 13, 2026
Type
4
Description
Statement of Changes in Beneficial Ownership
Download
Items per page
1-10 of 140
Sign up for email alerts
Receive company news, updates and other information
Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2025 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
